Skip to main content
logo
Lonza Group AG (SWX:LONN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
592.20
+6.40 (1.09%)
Aug 21, 2026, 5:31 PM CET

Revenue

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Integrated Biologics Revenue
3.71B3.65B2.88B
Advanced Synthesis Revenue
1.77B1.61B1.32B
Specialized Modalities Revenue
1.11B1.03B1.10B
Corporate Revenue
265.00M237.00M175.00M
Revenue (Other)
-523.00M--
Revenue (Total)
6.33B6.53B5.48B

Revenue by Geography

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Europe Revenue
-2.99B2.73B
North and Central America Revenue
-2.57B1.99B
Latin America Revenue
-102.00M78.00M
Asia Revenue
-860.00M673.00M
Australia & New Zealand Revenue
-4.00M4.00M
Other Geographic Revenue
-3.00M-
Revenue (Total)
6.33B6.53B5.48B

Adjusted EBITDA

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Integrated Biologics Core EBITDA
1.31B1.29B1.05B
Advanced Synthesis Core EBITDA
802.00M674.00M484.00M
Specialized Modalities Core EBITDA
249.00M176.00M192.00M
Corporate Core EBITDA
-42.00M-73.00M-68.00M
Operating Income (Other)
-906.00M-825.00M-745.00M
Operating Income (Total)
1.41B1.24B908.00M